Lung cancer cells expressing CD44 are enriched for stem‐like properties, and CD44‐positive cells show a higher level of expression for pluripotency markers (Oct‐4, Sox‐2) and increased resistance to cisplatin.24 This evidence concerns the gene POU5F1 and lung cancer.